Comments
Dr Reddy’s Laboratories Ltd on Thursday announced the appointment of Erez Israeli, former President and CEO of Enzymotec, as the Chief Operating Officer (COO), succeeding Abhijit Mukherjee, who will retire on March 31 after a 15-year career with the company.
Israeli will join Dr Reddy’s on April two as Chief Operating Officer and Global Head of Generics and PSAI, based out of Hyderabad.
He will report to Dr Reddy’s co-Chairman and CEO, GV Prasad, a company statement said.
In a career spanning over 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for, the statement said.
Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions of responsibility including Vice-President-Marketing & Sales for North America, Vice-President Asia Operations, President Teva API, Group Executive Vice-President, Head of Global Quality, and President and CEO Growth Markets, it said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.